Efficacy and safety of stereotactic ablative radiotherapy in patients with previous pneumonectomy.

@article{Levra2015EfficacyAS,
  title={Efficacy and safety of stereotactic ablative radiotherapy in patients with previous pneumonectomy.},
  author={Niccol{\`o} Giaj Levra and Andrea Riccardo Filippi and Alessia Guarneri and Serena Badellino and Cristina de F. Mantovani and Enrico Ruffini and Umberto Ricardi},
  journal={Tumori},
  year={2015},
  volume={101 2},
  pages={
          148-53
        }
}
BACKGROUND Thoracic surgery for a newly diagnosed primary lung tumor following a previous pneumonectomy is rarely indicated. Stereotactic ablative radiotherapy (SABR) might represent a curative option. This report focuses on outcomes, toxicity and quality of life (QoL) after SABR. METHODS Nine patients were treated with SABR between 2004 and 2011; median time since surgery was 8.4 years. In 4 cases, a histological confirmation was possible with bronchoscopy. In 5 cases, the clinical proof of… CONTINUE READING